Metformin Hydrochloride 1000.00 mg + Empagliflozin 12.50 mg

GIBTULIO MET 1000mg | 12.5mg is a fixed dose combination medication that contains Metformin Hydrochloride and Empagliflozin. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control. Metformin is an oral antidiabetic drug that helps lower blood glucose levels by reducing glucose production in the liver and increasing insulin sensitivity. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by blocking glucose reabsorption by the kidneys, leading to increased glucose excretion in the urine. The combination of these two medications helps to control blood sugar levels effectively. GIBTULIO MET 1000mg | 12.5mg should be used in conjunction with a proper diet and exercise regimen as prescribed by your doctor.

Take GIBTULIO MET 1000mg | 12.5mg orally with meals, as directed by your doctor. Your dosage will depend on your medical condition and response to treatment. It is important to follow your doctor's instructions and never exceed the recommended dosage.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.